Wednesday, December 10, 2014

Shire CEO eyes deals, but no urgency to spend AbbVie breakup fee

A sign sits in front of Shire's manufacturing facility in Lexington, Massachusetts NEW YORK (Reuters) - Shire PLC's chief executive said he sees no urgency to spend the windfall the Dublin-based drugmaker received when AbbVie walked away from a $55 billion takeover bid earlier this year.








via Health News Headlines - Yahoo News http://ift.tt/1wzLyBS

No comments:

Post a Comment